General Information of This Metabolic Reaction (MR) (ID: MR003631)
Formula Reactant MMAE Product FCU-2711 Metabolite M4
Reactant Info Product Info
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Produce The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR003625 FCU-2711 MMAE Unclear FCU-2711 [1]
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR003629 MMAE FCU-2711 Metabolite M3 Unclear FCU-2711 [1]
MR003626 MMAE FCU-2711 Metabolite M6 Unclear FCU-2711 [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR003632 FCU-2711 Metabolite M4 FCU-2711 Metabolite M1 Unclear FCU-2711 [1]
References
1 Preclinical Characterization of the Distribution, Catabolism, and Elimination of a Polatuzumab Vedotin-Piiq (POLIVY(?)) Antibody-Drug Conjugate in Sprague Dawley Rats

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.